Global MR-Linac Market Strategic Research Report

Scope of the Report

The global MR-Linac market size is predicted to grow from US$ 697 million in 2025 to US$ 1,334 million in 2032; it is expected to grow at a CAGR of 10.6% from 2026 to 2032.

Magnetic resonance-guided radiation therapy system is a high-end tumor treatment equipment that deeply integrates magnetic resonance imaging (MR/MRI) with external beam radiation therapy devices, typically medical electronic linear accelerators, in both hardware and software.It aims to continuously acquire MR images with high soft-tissue contrast resolution before, during and even throughout treatment, and achieve more accurate dose delivery to tumors while better protecting surrounding normal tissues through online plan adaptation, real-time tracking and gating.In 2025, the global sales volume of MR-Linac was approximately 95 units, with an average price of about 7.5 million US dollars per unit, and the industry average gross profit margin stood at around 30%.

MR-Linac systems are evolving from "high-end demonstration equipment" to "capability platforms built around precision adaptive treatment". The focus of market competition is no longer merely the integration of imaging and radiotherapy hardware, but clinical workflow, online adaptive efficiency, motion management, physician team training, and hospital-wide collaboration capabilities. The current landscape is characterized by "dominance by a small number of system manufacturers, high entry barriers, and long verification cycles". On the one hand, accumulating clinical evidence and new product approvals are improving hospital acceptance; on the other hand, complex procedures, construction and operational difficulties still limit rapid popularization. Manufacturers that can simultaneously deliver robust treatment efficacy, efficiency and replicable deployment will have greater opportunities in the future.

Key Questions Addressed in this Report

What is the 10-year outlook for the global MR-Linac market?

What factors are driving MR-Linac market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do MR-Linac market opportunities vary by end market size?

How does MR-Linac break out by Type, by Application?

This report presents a comprehensive overview of the global MR-Linac market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• High-field MR-Linac
• Low-field MR-Linac

Segment by Application

• Prostate cancer
• Pancreatic cancer
• Liver cancer
• Lung cancer
• Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global MR-Linac market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Prostate cancer, Pancreatic cancer, Liver cancer evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact